Analystreport

Caladrius Biosciences Inc (NASDAQ: CLBS) had its "buy" rating re-affirmed by analysts at Chardan Capital.

Caladrius Biosciences, Inc.  (CLBS) 
Last caladrius biosciences, inc. earnings: 11/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: caladrius.com/investors/overview